Peter J Goadsby (P J Goadsby, Peter Goadsby)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 124

Top Venues

Cephalalgia : an international journal of headache

European journal of neurology

Neurology

Headache

This page only lists publications with an associated author ORCID identifier.

Publications

Arne May, Stefan Evers, Peter J Goadsby
Reply to the letter from Lansbergen et al. European journal of neurology 31 (3) (2024)
Peter J Goadsby, Stefan Evers, Amy A Gelfand, Richard B Lipton, Arne May, Patricia Pozo-Rosich, Jean Schoenen, Todd J Schwedt, Cristina Tassorelli, Gisela Terwindt, Shuu-Jiun Wang
International Classification of Headache Disorders-4 - Work in Progress 1 . Cephalalgia : an international journal of headache 44 (2) (2024)
Nazia Karsan, Peter J Goadsby
Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy. CNS drugs 38 (7) (2024)
Peter J Goadsby, Deborah I Friedman, Dagny Holle-Lee, Genevieve Demarquay, Sait Ashina, Fumihiko Sakai, Brian Neel, Pranav Gandhi, Brett Dabruzzo, Jonathan H Smith, Yingyi Liu, Joel M Trugman
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. Neurology 103 (2) (2024)
Nazia Karsan, Lars Edvinsson, Laszlo Vecsei, Peter J Goadsby
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders. Annals of clinical and translational neurology 11 (7) (2024)
Arne May, Stefan Evers, Peter J Goadsby
Reply to the letter from Lansbergen et al. European journal of neurology 31 (3) (2024)
Andrew C Charles, Kathleen B Digre, Peter J Goadsby, Matthew Stuart Robbins, Andrew D Hershey, null null
Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache 64 (4) (2024)
Peter J Goadsby, Deborah I Friedman, Dagny Holle-Lee, Genevieve Demarquay, Sait Ashina, Fumihiko Sakai, Brian Neel, Pranav Gandhi, Brett Dabruzzo, Jonathan H Smith, Yingyi Liu, Joel M Trugman
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. Neurology 103 (2) (2024)
Andrew C Charles, Kathleen B Digre, Peter J Goadsby, Matthew Stuart Robbins, Andrew D Hershey, null null
Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache (2024)
Sing-Ngai Cheung, Renato Oliveira, Peter J Goadsby
Melatonin in hemicrania continua and paroxysmal hemicrania. Cephalalgia : an international journal of headache 44 (3) (2024)
Gianluca Coppola, Chiara Abagnale, Gabriele Sebastianelli, Peter J Goadsby
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks. Cephalalgia : an international journal of headache 44 (2) (2024)
Peter J Goadsby, Deborah I Friedman, Dagny Holle-Lee, Genevieve Demarquay, Sait Ashina, Fumihiko Sakai, Brian Neel, Pranav Gandhi, Brett Dabruzzo, Jonathan H Smith, Yingyi Liu, Joel M Trugman
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. Neurology 103 (2) (2024)
Nazia Karsan, Lars Edvinsson, Laszlo Vecsei, Peter J Goadsby
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders. Annals of clinical and translational neurology (2024)
Arne May, Stefan Evers, Peter J Goadsby
Reply to the letter from Lansbergen et al. European journal of neurology 31 (3) (2024)
Nazia Karsan, Lars Edvinsson, Laszlo Vecsei, Peter J Goadsby
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders. Annals of clinical and translational neurology 11 (7) (2024)
Nazia Karsan, Peter J Goadsby
Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy. CNS drugs (2024)
Andrew C Charles, Kathleen B Digre, Peter J Goadsby, Matthew Stuart Robbins, Andrew D Hershey, null null
Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache 64 (4) (2024)
Nazia Karsan, Lars Edvinsson, Laszlo Vecsei, Peter J Goadsby
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders. Annals of clinical and translational neurology 11 (7) (2024)
Andrew C Charles, Kathleen B Digre, Peter J Goadsby, Matthew Stuart Robbins, Andrew D Hershey, null null
Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache 64 (4) (2024)
Peter J Goadsby, Deborah I Friedman, Dagny Holle-Lee, Genevieve Demarquay, Sait Ashina, Fumihiko Sakai, Brian Neel, Pranav Gandhi, Brett Dabruzzo, Jonathan H Smith, Yingyi Liu, Joel M Trugman
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. Neurology 103 (2) (2024)
Nazia Karsan, Peter J Goadsby
Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy. CNS drugs 38 (7) (2024)
Robyn-Jenia Wilcha, Peter J Goadsby
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study. Cephalalgia : an international journal of headache 44 (9) (2024)
Peter J Goadsby
Update on cough, exertional and sex headache. Cephalalgia : an international journal of headache 44 (4) (2024)
Arne May, Stefan Evers, Peter J Goadsby
Reply to the letter from Lansbergen et al. European journal of neurology (2024)
Arne May, Stefan Evers, Peter J Goadsby
Reply to the letter from Lansbergen et al. European journal of neurology 31 (3) (2024)
Arne May, Stefan Evers, Peter J Goadsby
Reply to the letter from Lansbergen et al. European journal of neurology 31 (3) (2024)
Gina M Dumkrieger, Ryotaro Ishii, Peter J Goadsby
Flexible modeling of headache frequency fluctuations in migraine with hidden Markov models. Headache (2024)
Andrew C Charles, Kathleen B Digre, Peter J Goadsby, Matthew Stuart Robbins, Andrew D Hershey, null null
Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache 64 (4) (2024)
Andrew C Charles, Kathleen B Digre, Peter J Goadsby, Matthew Stuart Robbins, Andrew D Hershey, null null
Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache 64 (4) (2024)
Nazia Karsan, Lars Edvinsson, Laszlo Vecsei, Peter J Goadsby
Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders. Annals of clinical and translational neurology 11 (7) (2024)
Peter J Goadsby, Elena Ruiz de la Torre, Luminita Constantin, Caroline Amand
Social Media Listening and Digital Profiling Study of People With Headache and Migraine: Retrospective Infodemiology Study. Journal of medical Internet research 25 (2023)
Miguel Ruiz, Alexandra Cocores, Antonella Tosti, Peter J Goadsby, Teshamae S Monteith
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review. Cephalalgia : an international journal of headache 43 (2) (2023)
Peter J Goadsby, Elena Ruiz de la Torre, Luminita Constantin, Caroline Amand
Social Media Listening and Digital Profiling Study of People With Headache and Migraine: Retrospective Infodemiology Study. Journal of medical Internet research 25 (2023)
Linus Jönsson, Stephane Alexandre Regnier, Steven Kymes, Susanne F Awad, Brian Talon, Xin Ying Lee, Peter J Goadsby
Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial. Expert review of pharmacoeconomics & outcomes research (2023)
Alina Buture, Esther M Tomkins, Arif Shukralla, Emma Troy, Katie Conaty, Esther Macken, Roisin Lonergan, Jane Melling, Niamh Long, Kieran Birrane, Eamonn Shaikh, Peter J Goadsby, Martin H Ruttledge
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent headache or persistent post-traumatic headache in the majority of cases. Cephalalgia : an international journal of headache 43 (6) (2023)
Peter J Goadsby, Elena Ruiz de la Torre, Luminita Constantin, Caroline Amand
Social Media Listening and Digital Profiling Study of People With Headache and Migraine: Retrospective Infodemiology Study. Journal of medical Internet research 25 (2023)
Nazia Karsan, Ray Pyari Bose, Owen G O'Daly, Fernando Zelaya, Peter J Goadsby
Regional cerebral perfusion during the premonitory phase of triggered migraine: A double-blind randomized placebo-controlled functional imaging study using pseudo-continuous arterial spin labeling. Headache 63 (6) (2023)
Peter J Goadsby, Barbanti Piero, Giorgio Lambru, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures. European journal of neurology 30 (4) (2023)
Mateusz Chwolka, Peter J Goadsby, Andreas R Gantenbein
Comorbidity or combination - more evidence for cluster-migraine? Cephalalgia : an international journal of headache 43 (1) (2023)
Peter J Goadsby, Elena Ruiz de la Torre, Luminita Constantin, Caroline Amand
Social Media Listening and Digital Profiling Study of People With Headache and Migraine: Retrospective Infodemiology Study. Journal of medical Internet research 25 (2023)
Arne May, Stefan Evers, Peter J Goadsby, Massimo Leone, Gian Camillo Manzoni, Julio Pascual, Vanessa Carvalho, Michele Romoli, Katina Aleksovska, Patricia Pozo-Rosich, Rigmor H Jensen, null null
European Academy of Neurology guidelines on the treatment of cluster headache. European journal of neurology (2023)
Miguel Ruiz, Alexandra Cocores, Antonella Tosti, Peter J Goadsby, Teshamae S Monteith
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review. Cephalalgia : an international journal of headache 43 (2) (2023)
Peter J Goadsby, Barbanti Piero, Giorgio Lambru, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures. European journal of neurology 30 (4) (2023)
Mateusz Chwolka, Peter J Goadsby, Andreas R Gantenbein
Comorbidity or combination - more evidence for cluster-migraine? Cephalalgia : an international journal of headache 43 (1) (2023)
Alexander Gordon, Thomas Roe, María Dolores Villar-Martínez, David Moreno-Ajona, Peter J Goadsby, Jan Hoffmann
Effectiveness and safety profile of greater occipital nerve blockade in cluster headache: a systematic review. Journal of neurology, neurosurgery, and psychiatry (2023)
Peter J Goadsby, Elena Ruiz de la Torre, Luminita Constantin, Caroline Amand
Social Media Listening and Digital Profiling Study of People With Headache and Migraine: Retrospective Infodemiology Study. Journal of medical Internet research 25 (2023)
Francesca Puledda, Samaira Younis, Eva-Maria Huessler, Faraidoon Haghdoost, Marco Lisicki, Peter J Goadsby, Cristina Tassorelli
Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature. Cephalalgia : an international journal of headache 43 (3) (2023)
Edoardo Caronna, Thomas C van den Hoek, Hayrunnisa Bolay Belen, David Garcia Azorin, Ana Beatriz Gago-Veiga, Massimiliano Valeriani, Tsubasa Takizawa, Karl Messlinger, Robert E Shapiro, Peter J Goadsby, Messoud Ashina, Cristina Tassorelli, Hans-Christoph Diener, Gisela M Terwindt, Patricia Pozo-Rosich
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia : an international journal of headache 43 (1) (2023)
Miguel Ruiz, Alexandra Cocores, Antonella Tosti, Peter J Goadsby, Teshamae S Monteith
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review. Cephalalgia : an international journal of headache 43 (2) (2023)
Richard B Lipton, Andrew Blumenfeld, Christopher M Jensen, Robert Croop, Alexandra Thiry, Gilbert L'Italien, Beth A Morris, Vladimir Coric, Peter J Goadsby
Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials. Cephalalgia : an international journal of headache 43 (2) (2023)
Peter J Goadsby, Barbanti Piero, Giorgio Lambru, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures. European journal of neurology 30 (4) (2023)
Richard B Lipton, Andrew Blumenfeld, Christopher M Jensen, Robert Croop, Alexandra Thiry, Gilbert L'Italien, Beth A Morris, Vladimir Coric, Peter J Goadsby
Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials. Cephalalgia : an international journal of headache 43 (2) (2023)
Edoardo Caronna, Thomas C van den Hoek, Hayrunnisa Bolay Belen, David Garcia Azorin, Ana Beatriz Gago-Veiga, Massimiliano Valeriani, Tsubasa Takizawa, Karl Messlinger, Robert E Shapiro, Peter J Goadsby, Messoud Ashina, Cristina Tassorelli, Hans-Christoph Diener, Gisela M Terwindt, Patricia Pozo-Rosich
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia : an international journal of headache 43 (1) (2023)
Francesca Puledda, Samaira Younis, Eva-Maria Huessler, Faraidoon Haghdoost, Marco Lisicki, Peter J Goadsby, Cristina Tassorelli
Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature. Cephalalgia : an international journal of headache 43 (3) (2023)
Modar Khalil, Peter J Goadsby, María Dolores Villar-Martínez, Fiona Greenwood, Jan Hoffmann, Peter J Goadsby
Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real-world evidence. European journal of neurology 29 (8) (2022)
Nazia Karsan, Peter J Goadsby
New Oral Drugs for Migraine. CNS drugs 36 (9) (2022)
Nazia Karsan, Karthik Nagaraj, Peter J Goadsby
Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms. The journal of headache and pain 23 (1) (2022)
Peter J Goadsby, Barbanti Piero, Giorgio Lambru, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures. European journal of neurology (2022)
Weera Supronsinchai, Jan Hoffmann, Simon Akerman, Peter J Goadsby
KCl-induced repetitive cortical spreading depression inhibiting trigeminal neuronal firing is mediated by 5-HT<sub>1B/1D</sub> and opioid receptors. Cephalalgia : an international journal of headache 42 (13) (2022)
Lalani Carlton Jones, Peter J Goadsby
Same-Day Bilateral Decubitus CT Myelography for Detecting CSF-Venous Fistulas in Spontaneous Intracranial Hypotension. AJNR. American journal of neuroradiology 43 (4) (2022)
Michael Graber, Adrian Scutelnic, Antonia Klein, Francesca Puledda, Peter J Goadsby, Christoph J Schankin
Natural course of visual snow syndrome: a long-term follow-up study. Brain communications 4 (5) (2022)
Michel D Ferrari, Peter J Goadsby, Rami Burstein, Tobias Kurth, Cenk Ayata, Andrew Charles, Messoud Ashina, Arn M J M van den Maagdenberg, David W Dodick
Migraine. Nature reviews. Disease primers 8 (1) (2022)
Jean Schoenen, Agneta Henriette Snoer, Roemer B Brandt, Rolf Fronczek, Diana Y Wei, Chin-Sang Chung, Hans-Christoph Diener, David W Dodick, Denys Fontaine, Peter J Goadsby, Manjit Singh Matharu, Arne May, James S McGinley, Stewart J Tepper, Rigmor Højland Jensen, Michel D Ferrari, null null, null null
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache. Cephalalgia : an international journal of headache 42 (14) (2022)
Peter J Goadsby, Barbanti Piero, Giorgio Lambru, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures. European journal of neurology (2022)
Margarida Martins-Oliveira, Simon Akerman, Philip R Holland, Isaura Tavares, Peter J Goadsby
Pharmacological modulation of ventral tegmental area neurons elicits changes in trigeminovascular sensory processing and is accompanied by glycemic changes: Implications for migraine. Cephalalgia : an international journal of headache 42 (13) (2022)
Peter J Goadsby
Reader Response: Clinical Characterization of Delayed Alcohol-Induced Headache: A Study of 1,108 Participants. Neurology 96 (16) (2021)
Nazia Karsan, Abigail Peréz-Rodríguez, Karthik Nagaraj, Ray Pyari Bose, Peter J Goadsby
The migraine postdrome: Spontaneous and triggered phenotypes. Cephalalgia : an international journal of headache 41 (6) (2021)
Jessica Ailani, Richard B Lipton, Peter J Goadsby, Hua Guo, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M Trugman, null null
Atogepant for the Preventive Treatment of Migraine. The New England journal of medicine 385 (8) (2021)
Diana Y Wei, Peter J Goadsby
Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster headache attacks. Cephalalgia : an international journal of headache 41 (8) (2021)
Peter J Goadsby, Michel Lantéri-Minet, Martin C Michel, Mario Peres, Mamoru Shibata, Andreas Straube, Tissa Wijeratne, Caty Ebel-Bitoun, Luminita Constantin, Simon Hitier
21st century headache: mapping new territory. The journal of headache and pain 22 (1) (2021)
Michel Dominique Ferrari, Uwe Reuter, Peter J Goadsby, Gabriel Paiva da Silva Lima, Subhayan Mondal, Shihua Wen, Nadia Tenenbaum, Shaloo Pandhi, Michel Lanteri-Minet, Tracy Stites
Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study. Journal of neurology, neurosurgery, and psychiatry (2021)
Andrew C Charles, Sinifunanya E Nwaobi, Peter J Goadsby
Inflammation in migraine…or not…: A critical evaluation of the evidence. Headache (2021)
Francesca Puledda, Christoph J Schankin, Owen O'Daly, Dominic Ffytche, Ozan Eren, Nazia Karsan, Steve C R Williams, Fernando Zelaya, Peter J Goadsby
Localised increase in regional cerebral perfusion in patients with visual snow syndrome: a pseudo-continuous arterial spin labelling study. Journal of neurology, neurosurgery, and psychiatry 92 (9) (2021)
Messoud Ashina, Peter J Goadsby, Uwe Reuter, Stephen Silberstein, David W Dodick, Fei Xue, Feng Zhang, Gabriel Paiva da Silva Lima, Sunfa Cheng, Daniel D Mikol
Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial. European journal of neurology 28 (5) (2021)
Diana Y Wei, Peter J Goadsby
Cluster headache pathophysiology - insights from current and emerging treatments. Nature reviews. Neurology 17 (5) (2021)
Francesca Puledda, David Moreno-Ajona, Peter J Goadsby
Exploding head syndrome (a.k.a. episodic cranial sensory shock) responds to single-pulse transcranial magnetic stimulation. European journal of neurology 28 (4) (2021)
Cristina Tassorelli, Hans-Christoph Diener, Stephen D Silberstein, David W Dodick, Peter J Goadsby, Rigmor H Jensen, Delphine Magis, Patricia Pozo-Rosich, Hsiangkuo Yuan, Daniele Martinelli, Thomas van den Hoek, Marie Deen, Messoud Ashina, Gisela M Terwindt
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine. Cephalalgia : an international journal of headache 41 (11-12) (2021)
Michel Lanteri-Minet, Peter J Goadsby, Uwe Reuter, Shihua Wen, Peggy Hours-Zesiger, Michel D Ferrari, Jan Klatt
Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful: results from the LIBERTY study. Journal of neurology, neurosurgery, and psychiatry 92 (5) (2021)
Kevin O'Gallagher, Francesca Puledda, Owen O'Daly, Matthew Ryan, Luke Dancy, Philip J Chowienczyk, Fernando Zelaya, Peter J Goadsby, Ajay M Shah
Neuronal nitric oxide synthase regulates regional brain perfusion in healthy humans. Cardiovascular research (2021)
Peter J Goadsby, Luminita Constantin, Caty Ebel-Bitoun, Iva Igracki Turudic, Simon Hitier, Caroline Amand-Bourdon, Andrew Stewart
Multinational descriptive analysis of the real-world burden of headache using the Migraine Buddy application. European journal of neurology 28 (12) (2021)
Francesca Puledda, Owen O'Daly, Christoph Schankin, Dominic Ffytche, Steven Cr Williams, Peter J Goadsby
Disrupted connectivity within visual, attentional and salience networks in the visual snow syndrome. Human brain mapping 42 (7) (2021)
Peter J Goadsby, Uwe Reuter, Michel Lanteri-Minet, Gabriel Paiva da Silva Lima, Peggy Hours-Zesiger, Chrystel Fernandes, Shihua Wen, Nadia Tenenbaum, Aditi Kataria, Michel D Ferrari, Jan Klatt
Long-Term Efficacy and Safety of Erenumab: Results From 64 Weeks of the LIBERTY Study. Neurology (2021)
Hans-Christoph Diener, Cristina Tassorelli, David W Dodick, Stephen D Silberstein, Richard B Lipton, Messoud Ashina, Werner J Becker, Michel D Ferrari, Peter J Goadsby, Patricia Pozo-Rosich, Shuu-Jiun Wang, Timothy T Houle, Thomas C van den Hoek, Daniele Martinelli, Gisela M Terwindt, null null
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia : an international journal of headache 40 (10) (2020)
Michele Viana, Grazia Sances, Salvatore Terrazzino, Chiara Zecca, Peter J Goadsby, Cristina Tassorelli
Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study. Cephalalgia : an international journal of headache 41 (2) (2020)
Francesca Puledda, Christoph J Schankin, Peter J Goadsby
Visual snow syndrome: A clinical and phenotypical description of 1,100 cases. Neurology 94 (6) (2020)
Calvin Chan, Peter J Goadsby
CGRP pathway monoclonal antibodies for cluster headache. Expert opinion on biological therapy 20 (8) (2020)
David W Dodick, Peter J Goadsby, Christian Lucas, Rigmor Jensen, Jennifer N Bardos, James M Martinez, Chunmei Zhou, Sheena K Aurora, Jyun Yan Yang, Robert R Conley, Tina Oakes
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment. Cephalalgia : an international journal of headache 40 (9) (2020)
Calvin Chan, Peter J Goadsby
Recent Advances in Pharmacotherapy for Episodic Migraine. CNS drugs 33 (11) (2020)
Michele Viana, Francesca Puledda, Peter J Goadsby
Visual snow syndrome: a comparison between an Italian and British population. European journal of neurology 27 (10) (2020)
Peter J Goadsby, María Dolores Villar-Martínez, Peter J Goadsby, Jan Hoffmann
Primary cough headache treated with non-invasive vagal nerve stimulation. Neurology 95 (13) (2020)
Peter J Goadsby, Stefan Evers
International Classification of Headache Disorders - ICHD-4 alpha. Cephalalgia : an international journal of headache 40 (9) (2020)
Francesca Puledda, Dominic Ffytche, David J Lythgoe, Owen O'Daly, Christoph Schankin, Steven C R Williams, Peter J Goadsby
Insular and occipital changes in visual snow syndrome: a BOLD fMRI and MRS study. Annals of clinical and translational neurology 7 (3) (2020)
Dimitris Fotis Sakellariou, Alexander David Nesbitt, Sean Higgins, Sandor Beniczky, Jan Rosenzweig, Panagis Drakatos, Nadia Gildeh, Patrick Brian Murphy, Brian Kent, Adrian John Williams, Meir Kryger, Peter J Goadsby, Guy Doron Leschziner, Ivana Rosenzweig
Co-activation of rhythms during alpha band oscillations as an interictal biomarker of exploding head syndrome. Cephalalgia : an international journal of headache 40 (9) (2020)
Francesca Puledda, Muriel M K Bruchhage, Owen G O'Daly, Dominic Ffytche, Steven C R Williams, Peter J Goadsby
Occipital cortex and cerebellum gray matter changes in visual snow syndrome. Neurology 95 (13) (2020)
Peter J Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo H Bonner, Feng Zhang, Ian K Wright, Denise E Chou, Jan Klatt, Hernan Picard, Robert A Lenz, Daniel D Mikol
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE study. Neurology 95 (5) (2020)
Christoph J Schankin, Francesca Puledda, Peter J Goadsby
Visual snow syndrome: is it normal or a disorder - and what to do with patients? European journal of neurology 27 (12) (2020)
Lars Edvinsson, Peter J Goadsby
Discovery of CGRP in relation to migraine. Cephalalgia : an international journal of headache 39 (3) (2020)
Peter J Goadsby, Stephen D Silberstein, Paul P Yeung, Joshua M Cohen, Xiaoping Ning, Ronghua Yang, David W Dodick
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study. Neurology 95 (18) (2020)
María Dolores Villar-Martínez, Peter J Goadsby, Peter J Goadsby
Eptinezumab for the preventive treatment of migraine. Pain management 11 (2) (2020)
Peter J Goadsby, Andrew M Blumenfeld, Richard B Lipton, David W Dodick, Kavita Kalidas, Aubrey M Adams, Abhijeet Jakate, Chengcheng Liu, Armin Szegedi, Joel M Trugman
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications. Cephalalgia : an international journal of headache 41 (5) (2020)

Peter J Goadsby.css-eqlu8i{font-size:small;padding-left:4px;} (P J Goadsby, Peter Goadsby)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter J Goadsby (P J Goadsby, Peter Goadsby)